Elevance Health Inc header image

Elevance Health Inc

ELV

Equity

ISIN null / Valor 26124340

New York Stock Exchange, Inc (2025-11-21)
USD 321.73+2.47%

Elevance Health Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Elevance Health Inc is a healthcare company that provides remote exam kits to members in five affiliated health plans, enabling doctors to conduct thorough examinations during telehealth visits. The kits allow for listening to patients' heart and lung sounds, as well as examining their mouths and ears. The company's focus on enhancing telehealth services through innovative technology demonstrates its commitment to improving patient care and access to healthcare services.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (23.10.2025):

Elevance Health Inc reported its third quarter 2025 financial results, showing significant growth and disciplined execution. The company achieved an operating revenue of $50.1 billion, marking a 12% increase from the same quarter last year, and reported a diluted EPS of $5.32. Elevance Health also reaffirmed its full-year guidance, emphasizing continued commitment to shareholder returns and sustainable growth.

Operating Revenue Growth

In the third quarter of 2025, Elevance Health Inc achieved an operating revenue of $50.1 billion, representing a 12% increase compared to the third quarter of 2024. This growth was driven by higher premium yields in the Health Benefits segment, recent acquisitions, and an expansion in Medicare Advantage membership.

Earnings Per Share

The company reported a diluted earnings per share (EPS) of $5.32 for the third quarter of 2025, with an adjusted diluted EPS of $6.03. These results reflect Elevance Health's strong financial performance and effective cost management strategies.

Guidance and Shareholder Returns

Elevance Health reaffirmed its full-year 2025 guidance, maintaining a benefit expense ratio of approximately 90.0% and an adjusted diluted EPS of around $30.00. Additionally, the company returned $3.3 billion of capital to shareholders year-to-date through share repurchases and dividends, underscoring its commitment to delivering value to investors.

Summarized from source with an LLMView Source

Key figures

-20.3%1Y
-35.6%3Y
5.27%5Y

Performance

36.4%1Y
28.8%3Y
27.7%5Y

Volatility

Market cap

71501 M

Market cap (USD)

Daily traded volume (Shares)

1,173,833

Daily traded volume (Shares)

1 day high/low

369.62 / 365.11

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Edwards Lifesciences Corp
Edwards Lifesciences Corp Edwards Lifesciences Corp Valor: 1065343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.24%USD 85.13
Dyne Therapeutics Inc
Dyne Therapeutics Inc Dyne Therapeutics Inc Valor: 56806425
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.27%USD 21.18
Boiron SA
Boiron SA Boiron SA Valor: 487646
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.95%EUR 26.60
Bright Horizons Family Solutions
Bright Horizons Family Solutions Bright Horizons Family Solutions Valor: 19920287
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.62%USD 101.12
Dr Reddy'S Laboratories Ltd
Dr Reddy'S Laboratories Ltd Dr Reddy'S Laboratories Ltd Valor: 1221723
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.07%USD 13.91
SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma AG & Co. KGaA SCHOTT Pharma AG & Co. KGaA Valor: 128964250
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.66%EUR 18.44
Coloplast A/S
Coloplast A/S Coloplast A/S Valor: 20259063
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.55%DKK 580.20
MannKind Corp
MannKind Corp MannKind Corp Valor: 35935511
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.21%USD 5.03
Essity AB
Essity AB Essity AB Valor: 36851944
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.79%SEK 260.90
Lifco Ab
Lifco Ab Lifco Ab Valor: 111355378
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.18%SEK 342.20